Cancer and infection: Estimates of the attributable fraction in 1990

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 6, 1997, Pages 387-400

  Pisani, Paola ^a   Parkin, D Maxwell ^a   Muñoz, Nubia ^a   Ferlay, Jacques ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER INCIDENCE; CANCER RISK; CLONORCHIASIS; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; KAPOSI SARCOMA; LIVER CANCER; NONHODGKIN LYMPHOMA; OPISTHORCHIASIS; PRIORITY JOURNAL; REVIEW; SEX RATIO; STOMACH CANCER; STOMACH LYMPHOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

ADOLESCENT; ADULT; CAUSALITY; CHILD; CHILD, PRESCHOOL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; POPULATION SURVEILLANCE; PREVALENCE; RISK; WORLD HEALTH;

EID: 0031008453     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (157)

1. Rous, P. Transmission of a malignant new growth by means of a cell-free filtrate. J. Am. Med. Assoc., 56: 198, 1911.
2. zur Hausen, H. Intracellular surveillance of persisting viral infections: human genital cancer results- from deficient cellular control of papillomavirus gene expression. Lancet, 2: 489-491, 1986.
3. Ames, B . N., Gold, L. S., and Willett, W. C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA, 92: 5258-5265, 1995.
4. IARC. Hepatitis Viruses. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publ. No. 59. Lyon, France: IARC, 1994.
5. Weed, D. L., and Gorelie, L. S. The practice of causal inference in cancer epidemiology. Cancer Epidemiol., Biomarkers & Prev., 5: 303-311, 1996.
6. Cole, P., and MacMahon, B. Attributable risk percent in case-control studies. Br. J. Prev. Soc. Med., 25: 242-244, 1971.
7. Bruzzi, P., Green, S. B., Byar, D. P., Brinton, L. A., and Schairer, C. Estimating the population attributable risk for multiple risk factors using casecontrol data. Am. J. Epidemiol., 122: 904-914, 1985.
8. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 654: 594-606, 1993.
9. UNO. World Population Prospects 1950-2050. The 1994 Revision. New York: United Nations, Population Division, 1995.
10. Lenoir, G. M.. Philip, T., and Sohier, R. Burkitt-type lymphoma: EBV association and cytogenetic markers in cases from various geographic locations. In: I. T. Magrath, G. T. O'Conor, and B. Ramot (eds). Progress in Cancer Research and Therapy, Vol. 27, pp. 283-296. New York: Raven Press, 1984.
11. Tanaka, K., Hiroata, T., Koga, S., Sugimachi, K., Kanematsu, T., Ohryohji, F., Nawata, H., Ishibashi, H., Maeda, Y., Kiyokawa, H., Tokunaga, K., Irita, Y., Takeshita, S., Arase, Y., and Nishino, N. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res., 57: 2842-2847, 1991.
12. Coursaget, P., Leboulleux, D., Le Cann, P., Bao, O., and Coll-Seck, A. M. Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal. Trans. R. Soc. Trop. Med. Hyg., 86: 552-553, 1992.
13. Stroffolini, T., Chiaramonte, M., Tiribelli, C., Villa, E., Simonetti, R. G., Rapicetta, M., Stazi, M. A., Bertin, T., Croce, S. L., Trande, P., Magliocco, A., and Chionne, P. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J. Hepatol., 16: 360-363, 1992.
14. Cordier, S., Le, T. B., Verger, P., Bard, D., Le, C. D., Larouze, B., Dazza, M. C., Hoang, T. Q., and Abenhaim, L. Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam. Int. J. Cancer, 55: 196-201, 1993.
15. Dazza, M. C., Meneses, L. V., Girard, P. M., Astagneau, P., Villaroel, C., Delaporte, E., and Larouze, B. Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique. Am. J. Trop. Med. Hyg., 48: 237-242, 1993.
16. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., and Tsa, J. H. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int. J. Cancer, 56: 619-621, 1994.
17. Sun, C. A., Farzadegan, H., You, S. L.. Lu, S. N., Wu, M. H., Wolfe, L., Hardy, W., Huang, G. T., .Yang, P. M., Lee. H. S., and Chen, C. J. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol. Biomarkers & Prev., 5: 173-178, 1996.
18. Tanaka, H., Hiyama, T., Okubo, Y., Kitada, A., and Fujimoto, I. Primary liver cancer incidence rates related to hepatitis C virus infection: a correlational study in Osaka, Japan. Cancer Causes & Control, 5: 61-65, 1994.
19. Tanaka, H., Hiyama, T., Tsukuma, H., Fujimoto, I., Yamano, H., Okubo, Y., and Kitada, A. Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data. Jpn. J. Cancer Res., 85: 485-490, 1994.
20. Mencarini, P., De Luca, A., Antinori, A., Maiuro, G., Spedini, G., Bailly, C., and Tamburrini, E. Prevalence of anti-HCV antibodies in Cameroon. Trans. R. Soc. Trop. Med. Hyg., 85: 654-655, 1991.
21. Develoux, M., Meynard, D., and Delaporte, E. Low rate of hepatitis C virus antibodies in blood donors and pregnant women from Niger. Trans. R. Soc. Trop. Med. Hyg., 86: 553, 1992.
22. Kew, M. C., Houghton, M, Choo, Q. L., and Kuo, G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet, 335: 873-874, 1990.
23. Chuang, W. L., Chang. W. Y., Lu, S. N., Su, W. P., Lin, Z. Y., Chen, S. C, Hsich. M. Y., Wang, L. Y., You, S. L., and Chen, C. J. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A casecontrol study. Cancer (Phila.), 69: 2052-2054, 1992.
24. Walter, S. D. Effects of interactions, confounding and observational error on attributable risk estimation. Am. J. Epidemiol., 171: 598-604, 1983.
25. IARC. Schistosomes, Liver Flukes and Helicobacter pylori. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publ. No. 61. Lyon, France: IARC, 1994.
26. Xiang, Z., Censini, S., Bayeli, P. F., Telford, J. L., Figura, N., Rappuoli, R., and Covacci, A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun., 63: 94-98, 1995.
27. Blaser, M. J., Pérez-Pérez, G. !.. Kleanthous, H., Cover, T. L., Peek, R. M., and Chyou, P. H. Infection with Helicobacler pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res., 55: 2111-2115, 1995.
28. Mégraud, F., Brassens-Rabbé, M. P., Denis, F., Belbouri, A., and Hoa, D. Q. Seroepidemiology of Campylobactcr pylori infection in various populations. J. Clin. Microbiol., 27: 1870-1873, 1989.
29. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341: 1329-1362. 1993.
30. Mufioz, N., and Pisani, P. Helicobacter pylori and gastric cancer. Eur. J. Gastr. Hepat., 6: 1097-1103, 1994.
31. Forman, D., Newell, D. G., Yamell, J. W. G., Stacey, A. R., Wald, N., and Sitas, F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J., 302; 1302-1305, 1991.
32. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325: 1127-1131, 1991.
33. Nomura, A., Stemmerman, G. N., Chyou, P. H., Kato, I., Perez-Perez, I., and Blaser, M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med., 325: 1132-1136, 1991.
34. Webb, P. M.. Yu, M., Forman, D., Henderson, B. E., Newell, D. G., Yuan, J-M., Gao, Y-T., and Ross, R. K. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int. J. Cancer, 67: 603-607, 1996.
35. Lin, J. T., Wang, L. Y., Wang, J. T., Wang, T. H., Yang, C. S., and Chen, C. J. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res., 15: 603-606, 1995.
36. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich, N., Vogelman, J. H., and Friedman, G. D. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330: 1267-1271, 1994.
37. IARC. Human Papillomaviruses. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publ. No. 64. Lyon, France: IARC, 1995.
38. Muñoz, N., Bosch, F. X., Ngelangel, C., Chichareon, S., Chaouki, N., Herrero, R., Miejer, C. J. L. M., and Walboomers, J. M. M. Risk of invasive cervical cancer by types of HPV: a multi-centre case-control study. Brisbane, Australia: Proceedings of the 15th International Papillomavirus Workshop, 69, 1996.
39. Asato, T., Nakajima, Y., Nagamine, M., Nakashima, Y., Takei, H., Maehama, T., Yamashiro, T., Higashi, M., Nakayama, M., and Kanazawa, K. Correlation between the progression of cervical dysplasia and the prevalence of human papillomavirus. J. Infect. Dis., 169: 940-941, 1994.
40. Rosenfeld, W. D., Vermund, S. H., Wentz, S. J., and Burk, R. D. High prevalence rate of human papillomavirus infection and association with abnormal Papanicolaou smears in sexually active adolescents. Am. J. Dis. Child., 143: 1443-1447, 1989.
41. Moscicki, A. B., Palefsky, J., Gonzales, J., and Schoolnik, G. K. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr. Res., 28: 507-513, 1990.
42. Ley, C., Bauer, H. M., Reingold, A., Schiffman, M. H., Chambers, J. C., Tashiro, C. J., and Manos, M. M. Determinants of genital human papillomavirus infection in young women. J. Natl. Cancer Inst., 83: 997-1003, 1991.
43. Bauer, H. M., Hildesheim, A., Schiffman, M. H., Glass, A. G., Rush, B. B., Scott, D. R., Cadell, D. M., Kurman, R. J., and Manos, M. M. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex. Transm. Dis., 20: 274-278, 1993.
44. Munoz, N., Bosch, F. X., De SanJose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Manos, C., and Ascunce, N. The causal link between human papillomavirus and invasive cervical cancer: a population-based casecontrol study in Colombia and Spain. Int. J. Cancer, 52: 743-749, 1992.
45. Eluf-Neto, J., Booth, M., Munoz, N., Bosch, F. X., Meijer, C. J. L. M, and Walboomers, J. M. M. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer, 69: 114-119, 1994.
46. Bosch, F. X., Manos, M. M, Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst., 87: 796-802, 1995.
47. Van den Brule, A. J. C, Walboomers, J. M. M., du Maine, M., Kenemans, P., and Meijer, C. J. L. M. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int. J. Cancer, 48: 404-408, 1991.
48. Hording, U., Teglbiaerg, C. S., Visfeldt, J., and Bock, J. E. Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: a search for a possible impact of HPV on vulvar cancer prognosis. Int. J. Cancer, 55: 394-396, 1993.
49. Dillner, J. Serology of human papillomavirus. Cancer J., 8: 264-269, 1995.
50. Beral, V., Peterman, T. A., Berkelman, R. L., and Jaffe, H. W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet, 335: 123-128, 1990.
51. Casabona, J., Melbye. M., Biggar, R.J. and the AIDS Registry Contributors. Kaposi's sarcoma and non-Hodgkin's lymphomas in European AIDS cases. No excess risk of Kaposis's sarcoma in Mediterranean countries. Int. J. Cancer, 47: 49-53, 1991.
52. Hoover, D. R., Black, C., Jacobson, L. P., Martinez Maza, O., Seminara, D., Saah, A., Von Roenn, J., Anderson, R., and Armenian, H. K. Epidemiologie analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am. J. Epidemiol., 138: 266-278, 1993.
53. Lundgren, J. D., Melbye, M., Pedersen, C., Rosenberg, P. S., and Gerstoff, J. Changing patterns of Kaposi's sarcoma in Danish Acquired Immunodeficiency Syndrome patients with complete follow-up. Am. J. Epidemiol., 141: 652-658, 1995.
54. Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F., and Mugerwa, J. W. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int. J. Cancer, 54: 26-36, 1993.
55. Bassett, M. T., Chokunonga, E., Mauchaza, B., Levy, L., Ferlay, J., and Parkin, D. M. Cancer in the African population of Harare, in Zimbabwe in 1990-1992. Int. J. Cancer, 63: 29-36, 1995.
56. Clumeck, N., Sonnet, J., Taelman, H., Maascart-Lemone, F., De Bruỳre, M., Vandepcrre, P., Dasnoy, J., Larcelis, L., Lamy, M., Jonas, C., Eyckmans, L., Noel, H., Vanhaeverbeek, M., and Butzler, J. P. Acquired Immunodeficiency Syndrome in African Patients. N. Engl. J. Med., 310: 492-497, 1984.
57. Piot, P., Quinn, T. C., Taelman, H., Feinsod, F. M., Bila Minlangu, K., Wobin, O., Mbendi, N., Mazebo, P., Ndangi, K., Stevens, W., Kalambayi, K., Mitchell, S., Bridts, C., and McCormick, J. B. Acquired Immunodeficiency Syndrome in a heterosexual population in Zaire. Lancet, 2: 65-69, 1984.
58. Van De Perre, P., Lepage, P., Kestelyn, P., Hekker, A. C., Rouvroy, D., Bogaerts, J., Kayihigi, J., Butzler, J. P., and Clumeck, N. Acquired Immunodeficiency Syndrome in Rwanda. Lancet, 2: 62-65, 984.
59. Buonaguro, F. M., Tomesello, M. L., Beth-Giraldo, E., Hatzakis, A., Mueller, N., Downing, R., Biryamwaho, B., Sempala, D. K., and Giraldo, G. Herpesviruslike DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int. J. Cancer, 65: 25-28, 1996.
60. Gao, S-J., Kingsley, L., Hoover, D. R., Spira, T. J., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Parry, P., Chang, Y., and Moore, P. S. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N. Engl. J. Med., 335: 233-241, 1996.
61. Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J., and Ganem, D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med., 2: 918-924, 1996.
62. Simpson, G. R., Schulz, T. F., Whitby, D., Cook, P. M., Boshoff, C., Rainbow, L., Howard, M. R., Gao, S-J., Bohenzky, R. A., Simmonds, P., Lee, C., de Ruiter, A., Hatzakis, A., Tedder, R. S., Weller, I. V. D., Weiss, R. A., and Moore, P. S., Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet, 348: 1133-1138, 1996.
63. Lennette, E. T., Blackbourn, D. J., and Levy, J. A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet, 348: 858-861, 1996.
64. Beral, V., Peterman, T., Berkelman, R., and Jaffe, H. AIDS-associated non-Hodgkin lymphoma. Lancet, 337: 805-809, 1991.
65. Serraino, D., Franceschi, S., Tirelli, U., and Monfardini, S. The epidemiology of acquired immunodeficiency syndrome and associated tumours in Europe. Ann. Oncol., 3: 595-603, 1992.
66. Pluda, J. M., Yarchoan, R., Jaffe, E. S., Feuerstein, I. M., Solomon, D., Steinberg, S. M., Wyvill, K. M., Raubitschek, A., Katz, D., and Broder, S. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann. Intern. Med., 113: 276-282, 1990.
67. Moore, R. D., Kessler, H., Richman, D. D., Fexner, C., and Chaisson, R. E. Non-Hodgkin's lymphoma in patients with HIV infection treated with zidovidine. J. Am. Med. Assoc., 205: 2208-2211, 1991.
68. Rabkin. C. S., Hilgartner, M. W., Hedberg, K. W., Aledort, L. M., Hatzakis, A., Eichinger, S., Eyster, M. E., White, G. C., II, Kessler, C. M., and Lederman, M. M. Incidence of lymphomas and other cancers in HIV-infected and HIVuninfected patients with hemophilia. J. Am. Med. Assoc., 267: 1090-1094,1992.
69. Gail, M. H., Pluda, J. M., Rabkin, C. S., Biggar, R. J., Goedert, J. J., Horm, J. W., Sondik, E. J., Yarchoan, R., and Broder, S. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J. Natl. Cancer Inst., 83: 695-701, 1991.
70. Lucas, S. B., Diomande, M., Hounnou, A., Beaumel, A., Giordano, C., and Kadio, A. HIV-associated lymphoma in Africa: an autopsy study in Côte d'Ivoire. Int. J. Cancer, 549: 20-24, 1994.
71. IARC. Human immunodeficiency viruses and human T-cell lymphotropic viruses. Monographs on the Evaluation of the Carcinogenic Risks to Humans. IARC Scientific Publ. No. 67. Lyon, France: IARC, 1996.
72. Henle, G., Henle, W.. Clifford, P., Diehl, V., Kafuko, G. W., Kirya, B. G., Klein, G., Morrow, R. H., Munube, G. M., Pike, P., Tukei, P. M., and Ziegler, J. L. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J. Nail. Cancer Inst., 43: 1147-1157, 1969.
73. de-Thé, G., Geser, A., Day, N. E., Tukei, P. M.. Williams, E. H., Ben, D. P., Smith, P. G., Dean, A. G., Bronkamm, G. W., Feorino, P., and Henle, W. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (Lond.), 274: 756-761, 1978.
74. Magrath, I. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res., 53: 133-270, 1990.
75. Evans, A. S., and Mueller, N. E. Virus and cancer: causal associations. Ann. Epidemiol., 1: 71-92, 1990.
76. Gutierrez, M. L, Bhatia, K., Barriga, F., Diez, B., Muriel, F. S., de Andréas, M. L., Epelman, S., Risueno, C, and Magrath, I. T. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood, 79: 3261-3266, 1992.
77. Lenoir, G. M., and Delecluse, H. J. Lymphoma and the immuno-compromised host. In: J-P. Revillard, and N. Wierzbicki (eds.), Immune Disorders and Opportunistic Infections. Local Immunity, vol. 5., pp. 173-183. Suresnes, France: Fondation Franco-Allemande, 1989.
78. Mueller, N., Mohar, A., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich, N., Polk, B. F., and Vogelman, J. Epstein-Barr vims antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int. J. Cancer, 49: 387-393, 1991.
79. Lehtinen, T., Lumio, J., Dillner, J., Hakama, M., Knekt P., Lethinen, M., Teppo, L., and Leinikki, P. Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies: a prospective study. Cancer Causes & Control, 4: 187-193, 1993.
80. Herbst, H., Niedobitek, G., Kneba, M., Hummel, M., Finn, T., Anagnostopoulos, I., Bergholz, M., Krieger, G., and Stein, H. High incidence of EpsteinBarr virus genomes in Hodgkin's disease. Am. J. Pathol., 137: 13-18, 1990.
81. Correa, P., and O'Conor, G. T. Epidemiologie patterns of Hodgkin's disease. Int. J. Cancer, 5: 192-201, 1971.
82. MacMahon, B. Epidemiology of Hodgkin's disease. Cancer Res., 26: 1189-1201, 1966.
83. Gutensohn, N., and Cole, P. Epidemiology of Hodgkin's disease in the young. Int. J. Cancer, 19: 595-604, 1977.
84. Munoz, N., Davidson. R. J. L., Witthoft, B., Ericsson, J. E., and de-Thé, G. Infectious mononucleosis and Hodgkin's disease. Int. J. Cancer, 22:10-13,1978.
85. Evans, A. S., Carvalho, R. P., Frost, P., Jamra, M., and Pozzi, D. H. Epstein-Barr virus infections in Brazil. II. Hodgkin's disease. J. Nail. Cancer Inst., 61: 19-26, 1978.
86. Evans, A. S., and Gutensohn, N. M. A population-based case control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int. J. Cancer, 34: 147-157, 1984.
87. Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich, N., Polk, B. F., and Vogelman, J. Hodgkin's disease and EpsteinBarr virus. Altered antibody pattern before diagnosis. N. Engl. J. Med., 320: 689-695, 1989.
88. Weiss, L. M., Movahed, L. A., Warnke, R. A., and Sklar, J. Detection of Epstein-Barr viral genomes in Reed-Sternbcrg cells of Hodgkin's disease. N. Engl. J. Med., 320: 502-506, 1989.
89. Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Muller Lantzsch, N., and Stein, H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Stemberg cells. Proc. Natl. Acad. Sei. USA, 88: 4766-4770, 1991. !
90. Armstrong, A. A., Weiss, L. M., Gallagher, A., Jones, D. B., Krajewski, A. S., Angus, B., Brown, G., Jack, A. S., Wilkins, B. S., Onions, D. E., and Jarre«, R. F. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia, 6: 869-874, 1992.
91. Weinreb, M., Day, P. J. R., Niggli, F, Powell, J. E., Raafat, F., Hesscling, P. B., Schneider, J. W., Hartley, P. S., Tzortzatou-Stathopoulou, F., Khalek, E. R. A., Mangoud, A., El-Safy, U. R., Madanat, F., Ai Sheyyab, M., Mpofu, C., Revesz, T., Rafii, R., Tiedemann, K., Waters, K. D., Barrantes, J. C., Nyongo, A., Riyat, M. S., and Mann, J. R. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch. Dis. Child., 74: 27-31, 1996.
92. Jarrett, R. F., Gallagher, A., Jones, D. B., Alexander, F. E., Krajewski, A. S., Kelsey, A., Adams, J., Angus, B., Gledhill, S., Wright, D. H., Cartwright, R. A., and Onions, D. E. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation lo age. J. Clin. Pathol., 44: 844-848, 1991.
93. Gledhill, S., Gallagher, A., Jones, D. B., Krajewski, A. S., Alexander, F. E., Klee, E., Wright, D. H., O'Brien, C, Onions, D. E., and Jarrett, R. F. Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br. J. Cancer, 64: 227-232, 1991.
94. Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M., and Young, L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet, 337: 320-322, 1991.
95. Weiss, L. M., Chen, Y. Y., Liu, X. F., and Shibale, D. Epstein Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymease chain reaction study. Am. J. Pathol., 139: 1259-1265, 1991.
96. Hildesheim, A., and Levine, P. Etiology of nasopharyngeal carcinoma: a review. Epidemiol. Rev., 15: 466-485, 1993.
97. de-Thé, G., and Ito, Y. (eds.), Nasopharyngeal Carcinoma: Etiology and Control. IARC Scientific Publ. No. 20. Lyon, France: IARC, 1978.
98. Zheng, X., Yan, L., Nilsson, B., Eklund, G., and Drettner, B. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. Acta Oncol, 33: 867-872, 1994.
99. Chen, J. Y., Chen, C. J., Liu, M. Y., Cho, S. M., Hsu, M. M., Lynn, T. C., Shieh, T., Tu, S. M., Beasley, R. P., Hwang, L. Y., Lee, H. H., Kuo, S. L., and Yang, C. S. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J. Med. Virol., 27: 269-273, 1989.
100. Henle, G., and Henle, W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer, 17: 1-7, 1976.
101. Joab, I., Nicolas, J., Schwaab, G., De-The, G., Clausse, B., Perricaudet, M., and Zeng, Y. Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer, 48: 647-649, 1991.
102. Giannoudis, A., Ergazaki, M., Segas, J., Giotakis, J., Adamopoulos, G., Gorgoulis, V., and Spandidos, D. A. Detection of Epstein-Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique. Cancer Lett., 89: 177-181, 1995.
103. Hording, U., Nielsen, H. W., Albeck, H., and Daugaard, S. Nasopharyngeal carcinoma: histopathological types and association with Epstein-Barr virus. Eur. J. Cancer B Oral Oncol., 29: 137-139, 1993.
104. Sasco, A. J. Screening for nasopharyngeal carcinoma. In: A. B. Miller, J. Chamberlain, N. E. Day, M. Hakama, and P. C. Prorok (eds.), Cancer Screening. Cambridge, United Kingdom: Cambridge University Press, 1991.
105. Zeng, Y., Zhang, L. G. H., Li, H. Y., Jan, M. G., Zhang, Q., Wu, Y. C., Wang, Y. S., and Su, G. R. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int. J. Cancer, 29: 139-141, 1982.
106. Hong, D., Yi, Z., Yiming, L., Zhengbao,. Z., Peizhong, W., Bingjun, L., Zhiming, P., Bifang, T., Yuming, Z., Wenjun, P., Zhengyi, Z., and Jueyan, W. Serological survey of nasopharynseal carcinoma in 21 cities of South China. Chin. Med. J. (Engl. Ed.), 108: 300-303, 1995.
107. Zeng, Y. Prospective studies on nasopharyngeal carcinoma and EpsteinBarr virus inducers. In: G. Wagner and Y. H. Zhang (eds.). Cancer of the Liver, Esophagus and Nasopharynx. Berlin: Springer-Verlag, I987.
108. Chan, C. K., Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich, N., Polk, B. F., and Vogelman, J. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes & Control, 2: 125-131, 1991.
109. Lanier, A. P., Henle, W., Bender, T., Henle, G., and Talbot, M. Epstein-Barr v irus-specific antibody liters in seven Alaskan natives before and after diagnosis of nasopharyngeal carcinoma. Int. J. Cancer, 26: 133-137, 1980.
110. Rowlands, D. C., Ito, M., Mangham, D. C., Reynolds, G., Herbst, H., Hallissey, M. T., Fielding, J. W., Newbold, K. M., Jones, E. L., Young, L. S., and Niedobitek, G. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br. J. Cancer, 68: 1014-1019, 1993.
111. Shibata, D., Hawes, D., Stemmerman, G. N., and Weiss, L. Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol. Biomarkers & Prev., 2: 213-217, 1993.
112. Shin, W. S., Kang, M. W., Kang, J. H., Choi, M. K., Ahn, B. M., Kim, J. K., Sun, H. S., and Min, K. W. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans. Am. J. Clin. Pathol., 105: 174-181, 1996.
113. Levine, P. H., Stemmerman, G., Lennette, E. T., Hildesheim, A., and Shibata, D. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int. J. Cancer, 60: 642-644, 1995.
114. Wong, M. P., Chung, L. P., Yuen, S. T., Leung, S. Y., Chan, S. Y., Wang, E., and Fu, K. H. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. J. Pathol., 777: 233-240, 1995.
115. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., and Uchino, H. Adult cell leukaemia: clinical and hématologie features of 16 cases. Blood, 50: 481-492, 1977.
116. Blattner, W. A., Blayney, D. W., Robert-Guroft, M., Samgadharan, M. G., Kalyanaraman, V. S., Sarin, P. S., Jaffe, E. S., and Gallo, R. C. The epidemiology of human T-cell leukaemia/lymphoma virus. J. Infect. Dis., 147:406-416, 1983.
117. Yoshida, M., Hattori, S., and Seike, M. Molecular biology of human T-cell leukaemia. Curr. Top. Microbiol. Immunol., 5: 157-175, 1985.
118. Tajima, K., and Hinuma, Y. Epidemiology of HTLV I/II in Japan and the world. Jpn. J. Cancer Res., 39: 129-149, 1992.
119. Verdier, M., Bonis, M., and Denis, F. A. The prevalence and incidence of HTLVs in Africa. In: M. Essex, S. Mboup, P. J. Kanki, and M. R. Kalengayi (eds.), AIDS in Africa. New York: Raven Press, 173-193, 1994.
120. Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y., and Hanaoka, M. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int. J. Cancer, 43: 1061-1064, 1989.
121. Tajima, K., and Kuroishi, T. Estimation of incidence rate of ATL among ATLV carriers in Kyushu, Japan. Jpn. J. Clin. Oncol., 15: 423-430, 1985.
122. Tokodome, S., Tokunaga, O., Shimamoto, Y., Miyamoto, Y., Sumida, L, Kikuchi, M., Takeshita, M., Ikeda, T., Fujiwara, K., Yoshihara, M., Yanagawa, T., and Nishizumi, M. Incidence of adult T-cell leukemia/lymphoma among human T-Iymphotropic virus type I carriers in Saga, Japan. Cancer Res., 49: 226-228, 1989.
123. Murphy, E. L., Hanchard, B., Figueroa, J. P., Gibbs, W. N. Lofters, W. S., Campbell, M., Gocdert, J. J., and Blattner, W. A. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer, 43: 250-253. 1989.
124. Cleghom, F. R., Manns, A., Falk, R., Hartge, P., Hanchard, B., Jack, N., Williams, E., Jaffe, E., White, F., Bartholomew, C., and Blattner, W. Effect of human T-Iymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J. Natl. Cancer Inst., 87: 1009-1014, 1995.
125. Levine, P. H., and Blattner, W. A. Tïie epidemiology of human virus associated haematologic malignancies. Leukemia, 6 (Suppl. 3): 54S-59S, 1992.
126. Parkin, D. M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'Abbq, K. A., and Wild, C. P. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int. J. Cancer, 48: 323-328, 1991.
127. Haswell Elkins, M. R., Mairiang, E., Mairiang, P., Chaiyakum, J., Chamadol, N., Loapaiboon, V., Sithithaworn, P., and Elkins, D. B. Crosssectional study of Opislhorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int. J. Cancer, 59: 505-509, 1994.
128. Parkin, D. M., Ohshima, H., Srivatanakul, P., and Vatanasapt, V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemic!., Biomarkers & Prev., 2: 537-544, 1993.
129. WHO. Control of foodbome trematode infections. WHO Technical Report Series No. 849. Geneva: WHO, 1995.
130. Vatanasapt, V., Martin, N., Sriplung, H., Chindavijak, K., Sontipong, S., Sriampom, S., Parkin, D. M., and Ferlay, J. Cancer in Thailand 1988-1991. IARC Technical Report No. 16. Lyon, France: IARC, 1993.
131. Mustacchi, P., and Shimkim, M. B. Cancer of the bladder and infestation with Schistosoma haematobium. J. Natl. Cancer Inst., 20: 825-841, 1958.
132. Gelfand, M., Weinberg, R. W., and Castle, W. M. Relationship between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet, 1: 1249-1251, 1967.
133. Elem, B., and Purohit, R. Carcinoma of the urinary bladder in Zambia. A quantitative estimation of Schistosoma haematobium infection. Br. J. Urol., 55: 275-278, 1983.
134. Vizcaino, A. P., Parkin, D. M, Boffetta, P., and Skinner, M. E. G. Bladder . cancer: epidemiology and risk factors in Bulawayo, Zimbabwe. Cancer Causes & Control, 5: 517-522, 1994.
135. Utroska, J. A., Chen, M. G., Dixon, H., Yoon, S., Helling-Borda, M., Hogerzeil, H. V., and Mott, K. E. An estimate of global needs for praziquantel within schistosomiasis control programmes. WHO/SCHISTO/89.102. Geneva: WHO, Division of Control of Tropical Diseases, 1989.
136. Doll, R., and Peto, R. The Causes of Cancer. Oxford, United Kingdom: Oxford University Press, 1981.
137. zur Hausen, H. Viruses in human cancers. Science (Washington DC), 254: 1167-1173, 1991.
138. Parkin, D. M., Stjemsward, J, and Muir, C. S. Estimates of the worldwide frequency of twelve major cancers. Bull. WHO, 62: 163-182, 1984.
139. Vousden, K. H., and Farrel, P. J. Viruses and human cancer. Br. Med. Bull., 3: 560-581, 1994.
140. Forman, D. The prevalence of Helicobacler pylori infection in gastric cancer. Aliment. Pharmacol. & Ther., Suppl. 2: 71-76, 1995.
141. Evans, A. S. Causation and disease: a chronological journey. Am. J. Epidemiol., 108: 249-258. 1978.
142. Evans, A. S. Viruses. In: D. Schottenfeld and J. P. Fraumeni, Jr. (eds.). Cancer Epidemiology and Prevention, pp. 364-390. Philadelphia: W. B. Saunders Company, 1982.
143. Henderson, B. E. Establishment of an association between a virus and a human cancer. J. Natl. Cancér Inst., 81: 320-321, 1989.
144. Chang, Y., Cesarman, E., Pessin, M. S., Lee, R, Culpepper, J., Knowles, D. M., and Moore, P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (Washington DC), 266: 1865-1869, 1994.
145. The Gambia Hepatitis Study Group. The Gambia Hepatitis Intervention Study. Cancer Res., 47: 5782-5787, 1987.
146. Sun, Z., Zhu, Y., Stjemsward, J., Hilleman, M., Zhen, Y., Hsia, C. C., Lu, J., Huang, F., Ni, Z., Ni, T., Chen, J. G., Yu, Z., Liu, Y., Liu, G., Chen, J. M., and Peto, R. Design, and Compliance of HBV Vaccination Trial on Newborns to Prevent Hepatocellular Carcinoma, and Five-Year Results of its Pilot Study. Cancer Detect. Prev., 15: 313-318, 1991.
147. Chang M. H., Chen C. J., Loi M. S., Kong M. S., WuT. C., Liang D. C., Hsu H. M., and Chen D. S. Hepatitis B mass vaccination program decreases childhood hepatocellular carcinoma in Taiwan. IX Triennal International Symposium on Viral Hepatitis and Liver Diseases, p. 263. Rome: 1996.
148. Hill, A. B. The environment and disease: association or causation? Proc. R. Soc. Med., 58: 295-300, 1965.
149. Montesano, R., and Wild, C. P. Chemical-viral interactions in carcinogenesis. In.: O. H. Iversen (ed.), New Frontiers in Cancer Causation: Proceedings of the Second International Conference on Theories of Carcinogenesis. Washington DC: Taylor & Francis, 1993.
150. Morris, J. D. H., Eddleston, A. L. W. F., and Crook, T. Viral infection and cancer. Lancet, 3-16: 754-758, 1995.
151. Ohshima, H., and Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutât. Res., 305: 253-264, 1994.
152. Parkin, D. M., Pisani, P., Lopez, A., and Masuyer, E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int. J. Cancer, 59: 494-504, 1994.
153. Murray, C. J. L., and Lopez, A. D. (eds.). Global Comparative Assessments in the Health Sector. Disease Burden, Expenditures and Intervention Packages. Geneva: WHO, 1994.
154. Fonseca, L. A. M., and Mameri, C. P. Mortalidade por cancer no estado de São Paulo. São Paulo, Brazil: Fundação SEADE, 1994.
155. Miller, B. A., Ries, L. A. G., Hankey., B. F., Devesa, S. S., and Edwards, B. K. (eds.). SEER Cancer Statistics Review: 1973-1990. J. Natl. Cancer. Inst., 1993.
156. Minister of Industry, Science, and Technology. Statistics Canada. Cancer in Canada 1990. Ottawa, Canada: Minister of Industry, Science, and Technology, 1994.
157. Hanai, A., and Fujimoto, I., and the Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1988: estimates based on data from ten population-based cancer registries. Jpn. J. Clin. Oncol., 24: 299-304, 1994.